| For: | Arsenos P, Gatzoulis KA, Tsiachris D, Dilaveris P, Sideris S, Sotiropoulos I, Archontakis S, Antoniou CK, Kordalis A, Skiadas I, Toutouzas K, Vlachopoulos C, Tousoulis D, Tsioufis K. Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach. World J Cardiol 2022; 14(3): 139-151 [PMID: 35432775 DOI: 10.4330/wjc.v14.i3.139] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v14/i3/139.htm |
| Number | Citing Articles |
| 1 |
Kevin Willy, Julia Köbe, Florian Reinke, Benjamin Rath, Christian Ellermann, Julian Wolfes, Felix K. Wegner, Patrick R. Leitz, Philipp S. Lange, Lars Eckardt, Gerrit Frommeyer. Usefulness of the MADIT-ICD Benefit Score in a Large Mixed Patient Cohort of Primary Prevention of Sudden Cardiac Death. Journal of Personalized Medicine 2022; 12(8) doi: 10.3390/jpm12081240
|
| 2 |
Jiwei Sun, Anhong Yu, Jianjun Yan, Yanhe Ma, Minghui Hua, Yanhong Chen, Wenjun Yue, Hong Zhang. Assessing the Risk of Frequent Premature Ventricular Contractions in Patients with Ischemic Cardiomyopathy: Development and Validation of a Nomogram Model. Journal of Imaging Informatics in Medicine 2026; doi: 10.1007/s10278-026-02000-3
|
| 3 |
Danielle Massarella, Rafael Alonso-Gonzalez. Updates in the management of congenital heart disease in adult patients. Expert Review of Cardiovascular Therapy 2022; 20(9) doi: 10.1080/14779072.2022.2125870
|
| 4 |
Mohsin Khan, Arshad Jahangir. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy. Heart Failure Clinics 2024; 20(4) doi: 10.1016/j.hfc.2024.06.007
|
| 5 |
Jiao Tang, Xue Deng, Ting Luo, Zhuoma Gesang, Zi-Ran Jia, Quzhun Danzeng, Tao Wang. Landiolol and septic ventricular arrhythmias: Revisiting the inflammation-fibrosis-Nav1.5/Cx43 electro-structural axis. World Journal of Cardiology 2026; 18(9): 120433 doi: 10.4330/wjc.120433
|
| 6 |
Ioannis Doundoulakis, Dimitris Tsiachris, Petros Arsenos, Athanasios Kordalis, Christos-Konstantinos Antoniou, Konstantinos Vlachos, Stergios Soulaidopoulos, Aggeliki Laina, Emmanuel Kanoupakis, Polychronis Dilaveris, Theofilos M. Kolettis, Konstantinos Trachanas, Iosif Xenogiannis, Panagiotis Korantzopoulos, Skevos Sideris, Nikolaos Fragakis, Vassilios P. Vassilikos, Konstantinos Tsioufis, Konstantinos A. Gatzoulis. Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: long-term outcomes from the PRESERVE EF study. Frontiers in Cardiovascular Medicine 2026; 13 doi: 10.3389/fcvm.2026.1787632
|
| 7 |
Petros Arsenos, Konstantinos Tsioufis, Konstantinos A Gatzoulis. Programmed ventricular stimulation for risk stratification in hypertrophic cardiomyopathy patients. European Heart Journal 2024; 45(26) doi: 10.1093/eurheartj/ehae311
|
| 8 |
Ilaria Marcantoni, Erica Iammarino, Alessandro Dell’Orletta, Laura Burattini. Prognostic Role of Electrocardiographic Alternans in Ischemic Heart Disease. Journal of Clinical Medicine 2025; 14(8) doi: 10.3390/jcm14082620
|
| 9 |
V. V. Presova, I. V. Leontyeva, S. A. Termosesov. Rhythm and conduction disorders in children with hypertrophic cardiomyopathy. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2026; 71(4) doi: 10.21508/1027-4065-2026-71-4-59-67
|
| 10 |
Mohsin Khan, Arshad Jahangir. The Uncertain Benefit from Implantable Cardioverter-Defibrillators in Nonischemic Cardiomyopathy. Cardiology Clinics 2023; 41(4) doi: 10.1016/j.ccl.2023.06.005
|
| 11 |
Anastasia Xintarakou, Ourania Kariki, Ioannis Doundoulakis, Petros Arsenos, Stergios Soulaidopoulos, Aggeliki Laina, Panagiotis Xydis, Athanasios Kordalis, Nikolaos Nakas, Alexia Theofilou, Charalampos Vlachopoulos, Konstantinos Tsioufis, Konstantinos A Gatzoulis. The Role of Genetics in Risk Stratification Strategy of Dilated Cardiomyopathy. Reviews in Cardiovascular Medicine 2022; 23(9) doi: 10.31083/j.rcm2309305
|
| 12 |
Laura Adina Stanciulescu, Maria Dorobantu, Radu Vatasescu. Targeting Ventricular Arrhythmias in Non-Ischemic Patients: Advances in Diagnosis and Treatment. Diagnostics 2025; 15(4) doi: 10.3390/diagnostics15040420
|
| 13 |
Xiaoping Xiang, Yanru Chen, Lijun Dai, Mohammad Farukh Hashmi. Effect of Perioperative Comprehensive Nursing Intervention on the Rehabilitation Effect of Radiofrequency Ablation for Patients with Hypertrophic Obstructive Cardiomyopathy. Contrast Media & Molecular Imaging 2022; 2022(1) doi: 10.1155/2022/6436073
|
| 14 |
Arie O. Verkerk, Ronald Wilders. The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data. Biomedicines 2023; 11(9) doi: 10.3390/biomedicines11092447
|
| 15 |
Natalia Przytuła, Ewa Dziewięcka, Mateusz Winiarczyk, Katarzyna Graczyk, Agnieszka Stępień, Paweł Rubiś. Hypertrophic cardiomyopathy and left ventricular non-compaction: Distinct diseases or variant phenotypes of a single condition?. World Journal of Cardiology 2024; 16(9): 496-501 doi: 10.4330/wjc.v16.i9.496
|
| 16 |
Petros Arsenos, Konstantinos A. Gatzoulis, Ageliki Laina, Ioannis Doundoulakis, Stergios Soulaidopoulos, Athanasios Kordalis, George Oikonomou, Konstantinos Triantafyllou, Nikolaos Fragakis, Vasillios Vasilikos, Konstantinos Tsioufis. QT interval extracted from 30-minute short resting Holter ECG recordings predicts mortality in heart failure. Journal of Electrocardiology 2022; 72 doi: 10.1016/j.jelectrocard.2022.03.013
|
| 17 |
Ilaria Marcantoni, Erica Iammarino, Agnese Sbrollini, Micaela Morettini, Cees A. Swenne, Laura Burattini. Electrocardiographic alternans as an additional criterion for cardioverter defibrillator implantation in primary prevention of sudden cardiac death. Biomedical Signal Processing and Control 2025; 110 doi: 10.1016/j.bspc.2025.108322
|
| 18 |
Francisco Sousa, Catarina Santos-Jorge, Pedro Freitas, Pedro M. Lopes, Sara Guerreiro, João Abecasis, Francisco Gama, Cláudia Silva, Rita Dos Reis Santos, Sérgio Maltês, Bruno Rocha, António Miguel Ferreira. Performance of the DERIVATE Risk Score 2.0 for predicting major arrhythmic events in non-ischemic cardiomyopathy: A Portuguese validation study. Revista Portuguesa de Cardiologia 2026; 45(7) doi: 10.1016/j.repc.2026.03.004
|